Back to search results

Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Metastatic Soft-tissue Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Mia Weiss, M.D.) · m.c.weiss@wustl.edu · 314-747-3096
    Contact: Principal Investigator (Mia Weiss, M.D.)
    Christine Auberle, M.D. (Sub-investigator)
    Angela Hirbe, M.D., Ph.D. (Sub-investigator)
    Chongliang (Jason) Luo, Ph.D. (Sub-investigator)
    Sasha Haarberg, PharmD, BCOP (Sub-investigator)
Study leads

  • Mia Weiss, M.D.

    Principal Investigator

    Washington University School of Medicine

View source on ClinicalTrials.gov(opens in a new tab)